Description
Recombinant monoclonal antibody to OPGL. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 9H7.
Target
OPGL
Target Alias Names
CD254, Tumor necrosis factor ligand superfamily member 11, TNFSF11, TNF superfamily member 11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, OPTB2, Receptor activator of nuclear factor kappa-B ligand, RANKL, hRANKL2, TNF-related activation-induced cytokine, TRANCE, sOdf, TNLG6B
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression